FURTHER ANALYSIS OF THE NEURO-PHARMACOLOGICAL PROFILE OF 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE (THA), AN ALLEGED DRUG FOR THE TREATMENT OF ALZHEIMERS-DISEASE

被引:91
作者
DRUKARCH, B [1 ]
LEYSEN, JE [1 ]
STOOF, JC [1 ]
机构
[1] JANSSEN PHARMACEUT,DEPT BIOCHEM PHARMACOL,B-2340 BEERSE,BELGIUM
关键词
D O I
10.1016/0024-3205(88)90431-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1011 / 1017
页数:7
相关论文
共 17 条
[1]   9-AMINO-1,2,3,4-TETRAHYDROACRIDINE (THA), AN ALLEGED DRUG FOR THE TREATMENT OF ALZHEIMERS-DISEASE, INHIBITS ACETYLCHOLINESTERASE ACTIVITY AND SLOW OUTWARD K+ CURRENT [J].
DRUKARCH, B ;
KITS, KS ;
VANDERMEER, EG ;
LODDER, JC ;
STOOF, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 141 (01) :153-157
[3]   TETRAHYDROAMINACRIN AS A DECURARISING AGENT [J].
GERSHON, S ;
SHAW, FH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1958, 10 (10) :638-641
[4]   TRANSMITTER DEFICITS IN ALZHEIMERS-DISEASE [J].
HARDY, J ;
ADOLFSSON, R ;
ALAFUZOFF, I ;
BUCHT, G ;
MARCUSSON, J ;
NYBERG, P ;
PERDAHL, E ;
WESTER, P ;
WINBLAD, B .
NEUROCHEMISTRY INTERNATIONAL, 1985, 7 (04) :545-563
[5]   INHIBITION OF CHOLINESTERASES BY TETRAHYDROAMINACRIN [J].
HEILBRONN, E .
ACTA CHEMICA SCANDINAVICA, 1961, 15 (06) :1386-&
[6]   ANTICHOLINESTERASE ACTIVITY OF TETRAHYDROAMINACRINE AND SUCCINYL CHOLINE HYDROLYSIS [J].
HO, AKS ;
FREEMAN, SE .
NATURE, 1965, 205 (4976) :1118-&
[9]   DOWN REGULATION OF SEROTONIN-S2 RECEPTOR-SITES IN RAT-BRAIN BY CHRONIC TREATMENT WITH THE SEROTONIN-S2 ANTAGONISTS - RITANSERIN AND SETOPERONE [J].
LEYSEN, JE ;
VANGOMPEL, P ;
GOMMEREN, W ;
WOESTENBORGHS, R ;
JANSSEN, PAJ .
PSYCHOPHARMACOLOGY, 1986, 88 (04) :434-444
[10]   RECEPTOR-BINDING PROFILE OF R-41-468, A NOVEL ANTAGONIST AT 5-HT2 RECEPTORS [J].
LEYSEN, JE ;
AWOUTERS, F ;
KENNIS, L ;
LADURON, PM ;
VANDENBERK, J ;
JANSSEN, PAJ .
LIFE SCIENCES, 1981, 28 (09) :1015-1022